Tuning the Aggregation of Plasmonic Probes to Shed Light on Diagnostic Strategies., PMID:40504768
Breadth of influenza A antibody cross-reactivity varies by virus isolation interval and subtype., PMID:40494885
Comparison of whole blood on filter strips with serum for avian influenza virus antibody detection in wild birds., PMID:40491934
No indication of highly pathogenic avian influenza infections in Dutch cows., PMID:40458141
DNA co-delivery of seasonal H1 influenza hemagglutinin nanoparticle vaccines with chemokine adjuvant CTACK induces potent immunogenicity for heterologous protection in vivo., PMID:40398322
A protective and broadly binding antibody class engages the influenza virus hemagglutinin head at its stem interface., PMID:40391889
Emergence of Antigenic Variants in Bovine H5N1 Influenza Viruses., PMID:40365787
Identification & genetic & virological characterisation of a human case of avian influenza A (H9N2) virus from Eastern India., PMID:40347502
M2e/NP Dual Epitope-Displaying Nanoparticles Enhance Cross-Protection of Recombinant HA Influenza Vaccine: A Universal Boosting Strategy., PMID:40333315
Impact of age and prior COVID-19 on the response to influenza a components in the 2020-2021 Fluzone vaccine., PMID:40328185
An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses., PMID:40301359
Chimeric virus-like particles of nodavirus displaying M2e of human and avian influenza A viruses as a potential dual-use vaccine: Inducing a broader immune response and protecting mice against viral infections., PMID:40286563
Sulfatide Binds to Influenza B Virus and Enhances Viral Replication., PMID:40284974
Multivalent H3 COBRA-based influenza vaccine elicits enhanced immune response in a pre-immune elderly ferret model., PMID:40267617
Conserved sites on the influenza H1 and H3 hemagglutinin recognized by human antibodies., PMID:40267182
Dual roles of influenza B virus neuraminidase mRNA vaccine in enhancing cross-lineage protection by supplementing inactivated split vaccination., PMID:40265888
Antibody function predicts viral control in newborn monkeys immunised with an influenza virus HA stem nanoparticle., PMID:40263387
Risk assessment of 2024 cattle H5N1 using age-stratified serosurveillance data., PMID:40262547
Influenza A hemagglutinin virus-like particles confer protection against influenza B virus infection., PMID:40230200
Cell binding, uptake, and infection of influenza A virus using recombinant antibody-based receptors., PMID:40207931
A monoclonal anti-hemagglutinin stem antibody modified with zanamivir protects against both influenza A and B viruses., PMID:40193611
Immunogenicity and protective efficacy of an inactivated bivalent vaccine containing two recombinant H1N1 and H3N2 swine influenza virus strains., PMID:40192841
Identification and characterization of a broadly neutralizing and protective nanobody against the HA1 domain of H5 avian influenza virus hemagglutinin., PMID:40192291
Live-attenuated pandemic H1N1 influenza vaccines expressing computationally optimized broadly reactive antigens (COBRAs) are immunogenic and protective in mice and ferrets., PMID:40186991
Identification of a seasonal influenza vaccine-induced broadly protective neuraminidase antibody., PMID:40178595
Neutralizing monoclonal antibodies as effective therapeutics and prophylactics against lethal H10N7 avian influenza infection in a mouse model., PMID:40176109
Broad Mucosal and Systemic Immunity in Mice Induced by Intranasal Booster With a Novel Recombinant Adenoviral Based Vaccine Protects Against Divergent Influenza A Virus., PMID:40145257
Characteristics of the First Domestic Duck-Origin H12N8 Avian Influenza Virus in China., PMID:40141383
Analysis of polyclonal and monoclonal antibody to the influenza virus nucleoprotein in different oligomeric states., PMID:40139568
A strategy of enhancing the protective efficacy of seasonal influenza vaccines by providing additional immunity to neuraminidase and M2e., PMID:40139072
Protection of Ducks Against Highly Pathogenic H5Nx Avian Influenza Viruses by HA Cleavage Site Peptide Vaccine., PMID:40133682
Emergence of a novel reassortant H3N3 avian influenza virus with enhanced pathogenicity and transmissibility in chickens in China., PMID:40069883
A novel tetravalent influenza vaccine based on one chimpanzee adenoviral vector., PMID:40023902
Cross-Reactive Fc-Mediated Antibody Responses to Influenza HA Stem Region in Human Sera Following Seasonal Vaccination., PMID:40006687
Targeted Elimination of Influenza Virus and Infected Cells with Near-Infrared Antiviral Photoimmunotherapy (NIR-AVPIT)., PMID:40006540
A single dose of inactivated influenza virus vaccine expressing COBRA hemagglutinin elicits broadly-reactive and long-lasting protection., PMID:39982912
Evaluation of a nanoparticle influenza vaccine in the pig model., PMID:39947075
Protective efficacy of a bivalent equine influenza H3N8 virus-like particle vaccine in horses., PMID:39938315
Structural characterization of influenza group 1 chimeric hemagglutinins as broad vaccine immunogens., PMID:39937865
Structural mapping of polyclonal IgG responses to HA after influenza virus vaccination or infection., PMID:39912630
Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine., PMID:39905416
Structurally convergent antibodies derived from different vaccine strategies target the influenza virus HA anchor epitope with a subset of VH3 and VK3 genes., PMID:39894881
Computational design and improvement of a broad influenza virus HA stem targeting antibody., PMID:39884272
Avian influenza mRNA vaccine encoding hemagglutinin provides complete protection against divergent H5N1 viruses in specific-pathogen-free chickens., PMID:39881325
Recombinant probiotic Escherichia coli delivers the polymeric protein of swine influenza virus for protection., PMID:39862797
Human naïve B cells recognize prepandemic influenza virus hemagglutinins., PMID:39854479
A Study on the Induction of Multi-Type Immune Responses in Mice via an mRNA Vaccine Based on Hemagglutinin and Neuraminidase Antigen., PMID:39852870
A gram-positive enhancer matrix particles vaccine displaying swine influenza virus hemagglutinin protects mice against lethal H1N1 viral challenge., PMID:39835123
Mucosal immunity elicited by a human-Fcγ receptor-I targeted intranasal vaccine platform enhances resistance against nasopharyngeal colonization of Streptococcus pneumoniae and induces broadly protective immunity against respiratory pathogens., PMID:39823848
Clade 2.3.4.4b but not historical clade 1 HA replicating RNA vaccine protects against bovine H5N1 challenge in mice., PMID:39809744
For research use only. Not for human or drug use.
